<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00597207</url>
  </required_header>
  <id_info>
    <org_study_id>Zoll-0100</org_study_id>
    <nct_id>NCT00597207</nct_id>
  </id_info>
  <brief_title>Circulation Improving Resuscitation Care (CIRC)</brief_title>
  <acronym>CIRC</acronym>
  <official_title>A Randomized Controlled Study Comparing Autopulse To Manual CPR In A CPR-First Protocol For Out-Of-Hospital Cardiac Arrest</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zoll Medical Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ullevaal University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Zoll Medical Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      During resuscitation of out of hospital cardiac arrest patients the use of a mechanical chest
      compression device Autopulse will improve survival compared to manual compressions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sudden out-of-hospital cardiac arrest (OOH-CA) remains a significant cause of death, in spite
      of recent declines in overall mortality from cardiovascular disease. Several studies document
      sub optimal quality of manual chest compressions and this may influence outcome. However,
      studies comparing manual and mechanical chest compressions have resulted in conflicted
      results. The investigators think this may be based on methodology and design issues of the
      trials as much as not focusing on training and experience in operating a mechanical device
      clinically. Therefore the investigators will focus on these issues and implement three phases
      in the study (In field training, Run In phase, and Study phase). The investigators will also
      focus on early use of mechanical CPR after arrival at patient side and randomization at
      arrival. In order to achieve this the investigators will follow the Norwegian CPR Guidelines
      with 3 min CPR before defibrillation and the 3 min algorithm. Quality of CPR will be
      monitored.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hospital Discharge</measure>
    <time_frame>From time of first contact until hospital discharge, up to 90 days.</time_frame>
    <description>Whether a subject was discharged alive from the hospital or alternatively died prior to discharge.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neurology</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sustained ROSC, Survival to 24 Hours, Hospital Discharge With a MRS ≤ 3, Process Outcomes: Number of Shocks, Duration of Pulselessness From 911 Call to ROSC, Hands-on Interval or Other Measures of CPR Quality</measure>
    <time_frame>during the case</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">4231</enrollment>
  <condition>Cardiac Arrest</condition>
  <condition>Cardiopulmonary Resuscitation</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mechanical CPR with AutoPulse</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Manual CPR</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AutoPulse</intervention_name>
    <description>Mechanical device that provides chest compression</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Manual</intervention_name>
    <description>Manual chest compression</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patents aged 18 years (or local age of consent) or more who suffer non-traumatic
             arrest of presumed cardiac etiology in an out-of-hospital setting and who do not meet
             any of the exclusion criteria below.

        Exclusion Criteria:

          -  Traumatic arrest (blunt, penetrating, burns)

          -  Arrest due to exsanguinations, strangulation, smoke inhalation, drug overdose,
             electrocution, hanging, drowning.

          -  Known or clinically apparent pregnancy

          -  Do Not Attempt to Resuscitate (DNAR) orders

          -  Apparent patient weight more than 225 kg (500 lbs)

          -  Wards of the state

          -  Prisoner

          -  CPR device other than AutoPulse

          -  Patients who are reached after 16 minutes after the time of emergency call (911). This
             exclusion is determined at the time of CRF abstraction, not during treatment of the
             patient.

               -  If patient is unaccompanied, or accompanied by a person or persons unfamiliar
                  with their his-tory, determination of these exclusion criteria will, perforce, be
                  left to the best estimation of the rescue personnel. At no time, should an
                  attempt to determine these criteria be allowed to delay the administration of
                  life-saving treatment.

                    -  These criteria will be determined in the best estimation of the rescue
                       personnel, or if the AutoPulse signals that the patient is outside the
                       parameters for AutoPulse deployment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lars Wik, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ullevaal University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Persse, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Houston Fire</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hillsborough Fire Rescue</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Houston Fire</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77002</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gold Cross EMS</name>
      <address>
        <city>Menasha</city>
        <state>Wisconsin</state>
        <zip>54952</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vienna EMS</name>
      <address>
        <city>Vienna</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nijmegen EMS</name>
      <address>
        <city>Nijmegen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Netherlands</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Norway</country>
  </removed_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 8, 2008</study_first_submitted>
  <study_first_submitted_qc>January 16, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 17, 2008</study_first_posted>
  <results_first_submitted>March 8, 2014</results_first_submitted>
  <results_first_submitted_qc>March 8, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 14, 2014</results_first_posted>
  <last_update_submitted>September 21, 2017</last_update_submitted>
  <last_update_submitted_qc>September 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CPR</keyword>
  <keyword>mechanical</keyword>
  <keyword>manual</keyword>
  <keyword>outcome</keyword>
  <keyword>survival</keyword>
  <keyword>quality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Out-of-Hospital Cardiac Arrest</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>iA-CPR</title>
          <description>Integrated Mechanical CPR with AutoPulse All subjects initially receive manual chest compressions. After randomization, subjects randomized to iA-CPR are moved to the device once it is ready and from thereon receive mechanical chest compressions.
AutoPulse: Mechanical device that provides chest compression</description>
        </group>
        <group group_id="P2">
          <title>M-CPR</title>
          <description>Manual CPR All subjects initially receive manual chest compressions. After randomization, subjects randomized to M-CPR continue to receive manual chest compressions.
Manual: Manual chest compression</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2099"/>
                <participants group_id="P2" count="2132"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2094"/>
                <participants group_id="P2" count="2125"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>iA-CPR</title>
          <description>Integrated Mechanical CPR with AutoPulse All subjects initially receive manual chest compressions. After randomization, subjects randomized to iA-CPR are moved to the device once it is ready and from thereon receive mechanical chest compressions.
AutoPulse: Mechanical device that provides chest compression</description>
        </group>
        <group group_id="B2">
          <title>M-CPR</title>
          <description>Manual CPR All subjects initially receive manual chest compressions. After randomization, subjects randomized to M-CPR continue to receive manual chest compressions.
Manual: Manual chest compression</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2099"/>
            <count group_id="B2" value="2132"/>
            <count group_id="B3" value="4231"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>18-59 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="706"/>
                    <measurement group_id="B2" value="734"/>
                    <measurement group_id="B3" value="1440"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>60-74 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="671"/>
                    <measurement group_id="B2" value="689"/>
                    <measurement group_id="B3" value="1360"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>75+ years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="722"/>
                    <measurement group_id="B2" value="709"/>
                    <measurement group_id="B3" value="1431"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="784"/>
                    <measurement group_id="B2" value="837"/>
                    <measurement group_id="B3" value="1621"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1315"/>
                    <measurement group_id="B2" value="1295"/>
                    <measurement group_id="B3" value="2610"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Hospital Discharge</title>
        <description>Whether a subject was discharged alive from the hospital or alternatively died prior to discharge.</description>
        <time_frame>From time of first contact until hospital discharge, up to 90 days.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>iA-CPR</title>
            <description>Integrated Mechanical CPR with AutoPulse All subjects initially receive manual chest compressions. After randomization, subjects randomized to iA-CPR are moved to the device once it is ready and from thereon receive mechanical chest compressions.
AutoPulse: Mechanical device that provides chest compression</description>
          </group>
          <group group_id="O2">
            <title>M-CPR</title>
            <description>Manual CPR All subjects initially receive manual chest compressions. After randomization, subjects randomized to M-CPR continue to receive manual chest compressions.
Manual: Manual chest compression</description>
          </group>
        </group_list>
        <measure>
          <title>Hospital Discharge</title>
          <description>Whether a subject was discharged alive from the hospital or alternatively died prior to discharge.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2094"/>
                <count group_id="O2" value="2125"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="196"/>
                    <measurement group_id="O2" value="233"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Neurology</title>
        <time_frame>30 days</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sustained ROSC, Survival to 24 Hours, Hospital Discharge With a MRS ≤ 3, Process Outcomes: Number of Shocks, Duration of Pulselessness From 911 Call to ROSC, Hands-on Interval or Other Measures of CPR Quality</title>
        <time_frame>during the case</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>iA-CPR</title>
          <description>Integrated Mechanical CPR with AutoPulse All subjects initially receive manual chest compressions. After randomization, subjects randomized to iA-CPR are moved to the device once it is ready and from thereon receive mechanical chest compressions.
AutoPulse: Mechanical device that provides chest compression</description>
        </group>
        <group group_id="E2">
          <title>M-CPR</title>
          <description>Manual CPR All subjects initially receive manual chest compressions. After randomization, subjects randomized to M-CPR continue to receive manual chest compressions.
Manual: Manual chest compression</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="2099"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="2132"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>CPR related injuries</sub_title>
                <description>CPR related injuries exceeding the normally expected seriousness</description>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="2099"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="2132"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="242" subjects_at_risk="2099"/>
                <counts group_id="E2" subjects_affected="225" subjects_at_risk="2132"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="33" subjects_affected="33" subjects_at_risk="2099"/>
                <counts group_id="E2" events="20" subjects_affected="20" subjects_at_risk="2132"/>
              </event>
              <event>
                <sub_title>Rib Fractures</sub_title>
                <counts group_id="E1" events="69" subjects_affected="69" subjects_at_risk="2099"/>
                <counts group_id="E2" events="31" subjects_affected="31" subjects_at_risk="2132"/>
              </event>
              <event>
                <sub_title>Subcutaneous emphysema</sub_title>
                <counts group_id="E1" events="21" subjects_affected="21" subjects_at_risk="2099"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="2132"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pulmonary edema</sub_title>
                <counts group_id="E1" events="159" subjects_affected="159" subjects_at_risk="2099"/>
                <counts group_id="E2" events="176" subjects_affected="176" subjects_at_risk="2132"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Sr. Director of Clinical Research</name_or_title>
      <organization>ZOLL Medical Corporation</organization>
      <phone>978-421-9655</phone>
      <email>uherken@zoll.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

